Letosteine
Clinical data | |
---|---|
Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H17NO4S2 |
Molar mass | 279.378 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Letosteine |
Articles |
---|
Most recent articles on Letosteine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Letosteine at Clinical Trials.gov Clinical Trials on Letosteine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Letosteine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Letosteine Discussion groups on Letosteine Patient Handouts on Letosteine Directions to Hospitals Treating Letosteine Risk calculators and risk factors for Letosteine
|
Healthcare Provider Resources |
Causes & Risk Factors for Letosteine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
- Pages with script errors
- Articles with changed DrugBank identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drug
- Antitussives
- Carboxylic acids
- Thioethers
- Thiazolidines
- Carboxylate esters
- Ethyl esters